Stay Updated with the Latest Cal-Maine Foods, Inc. CALM News in Real Time
Find CALM news now at Meyka AI. Stay informed with the latest Cal-Maine Foods, Inc. stocks updates, including price news, market analysis, and expert insights.
FTSE 100 Edges Up 0.09% as Iran Diplomacy Lifts UK Market Mood
Global markets ended the session on a slightly positive note as improving diplomatic signals around Iran helped calm investor nerves. The FTSE 100 moved higher even as energy stocks stayed under pressure. Traders reacted to easing geopolitical risk, softer oil prices, and stable currency movements. Overall sentiment tilted toward cautious optimism, with investors focusing on…
Australian Shares Set to Rise as Oil Prices Plunge 4.2%; Worley (ASX: WOR) Lifts FY26 EBITA Impact Forecast to AU$60M
Australian Shares are expected to open higher as a sharp decline in oil prices improves investor sentiment across the market. Lower crude prices have eased concerns about energy-driven inflation and supply disruptions linked to the Strait of Hormuz. At the same time, engineering giant Worley (ASX: WOR) has updated investors on the expected earnings impact…
FTSE 100 Swings Higher by 0.09% as DAX Falls 0.65% on Tech Rout
European markets delivered a mixed performance on Wednesday as investors balanced a sharp global technology selloff against easing geopolitical concerns in the Middle East. The FTSE 100 managed to stay in positive territory, while Germany’s DAX came under pressure from weakness in technology and semiconductor stocks. Market participants also monitored political developments in the UK…
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…